Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference [Yahoo! Finance]
VistaGen Therapeutics, Inc. (VTGN)
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vistagen.com
Company Research
Source: Yahoo! Finance
groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management will present and host one-on-one meetings during the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14 and 15, 2024 in New York City. 2024 RBC Capital Markets Global Healthcare Conference Shawn Singh, Chief Executive Officer, will participate in a fireside chat on Wednesday, May 15 at 4:05 p.m. Eastern Time. A webcast will be accessible through the "Events" page in the "Investors" section of the Company's website at www.Vistagen.com . Investors interested in arranging a one-on-one meeting during the conference should contact their RBC representative. About Vistagen Vistagen (Nasdaq: VTGN) is a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders. Five of Vistagen's clinical-stage neuroscience pipeline candidates belong to
Show less
Read more
Impact Snapshot
Event Time:
VTGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTGN alerts
High impacting VistaGen Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VTGN
News
- Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceBusiness Wire
- Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental FatigueBusiness Wire
- Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression [Seeking Alpha]Seeking Alpha
- Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) ConferenceBusiness Wire
- Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2Business Wire
VTGN
Earnings
- 2/13/24 - Beat
VTGN
Sec Filings
- 4/26/24 - Form 8-K
- 4/16/24 - Form DEF
- 4/5/24 - Form PRE
- VTGN's page on the SEC website